Clinical Trial

A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70

Active, Not Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated October 31, 2024 (before its estimated May 2025 completion). Its status may not reflect the trial's current state.
Summary
In this study we propose to determine outcomes of patients age 70 or older treated with radiation over 2 weeks given with temozolomide 75 mg/m2 daily during radiotherapy and as a post radiation treatment of 150 mg/m2 - 200 mg /m2 for 6 cycles or until the disease progresses.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2013-11-14; most recent amendment 2024-10-28.
Status change: Recruiting → Active, Not Recruiting 2024-10-28
Status change: Not Yet Recruiting → Recruiting 2014-09-29
Trial Details
NCT Number NCT01985087
Lead Sponsor University of Louisville
Collaborators: James Graham Brown Cancer Center
Conditions Glioblastoma
Enrollment 18 participants
Start Date 2014-09
Primary Completion 2025-05 (estimated)
Study Completion 2025-05 (estimated)
Updated on ClinicalTrials.gov 2024-10-31